Emory University’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-31,959
| Closed | -$2.33M | – | 46 |
|
|
2018
Q4 | $2.33M | Buy |
31,959
+4,275
| +15% | +$312K | 1.84% | 12 |
|
|
2018
Q3 | $2.42M | Buy |
27,684
+1,428
| +5% | +$125K | 1.59% | 27 |
|
|
2018
Q2 | $2.59M | Buy |
26,256
+4,940
| +23% | +$487K | 1.72% | 19 |
|
|
2018
Q1 | $2.54M | Buy |
21,316
+6,972
| +49% | +$830K | 1.81% | 17 |
|
|
2017
Q4 | $1.82M | Sell |
14,344
-6,316
| -31% | -$802K | 1.56% | 30 |
|
|
2017
Q3 | $2.43M | Sell |
20,660
-922
| -4% | -$108K | 1.92% | 5 |
|
|
2017
Q2 | $1.72M | Buy |
+21,582
| New | +$1.72M | 1.52% | 11 |
|